 "The pharmaceutical company reported 11 per cent YoY decline in sales at Rs 200 crore")
Shares of Procter & Gamble (P&G) Health slipped 6 per cent to Rs 5,330 on the BSE in the intra-day trade on Wednesday on profit booking. The company reported 10.8 per cent year on year (YoY) growth in net profit at Rs 48.90 crore for June quarter.
The pharmaceutical company reported 11 per cent YoY decline in sales at Rs 200 crore, as the business operations got impacted across the country following the nationwide lockdown imposed to contain the spread of Covid-19.
The company's EBITDA (earnings before interest, taxes, depreciation, and amortization) margin improved to 31.7 per cent from 30.82 per cent. The performance was driven by sales growth coupled with strategic choices in managing opex during the last two quarters impacted
